SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
dp_nj
Lv1
100 积分
2022-08-24 加入
最近求助
最近应助
互助留言
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms
7天前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
11天前
已完结
When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program
27天前
已关闭
Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer
1个月前
已完结
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
1个月前
已完结
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study
1个月前
已完结
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
1个月前
已完结
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H
1个月前
已完结
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non–Small Cell Lung Cancer
1个月前
已完结
没有进行任何应助
下载了【积分已退回】
27天前
感谢,帮大忙了,么么哒
4个月前
一下载【积分已退回】
4个月前
无人应助【积分已退回】
4个月前
无人应助【积分已退回】
4个月前
感谢,速度真快,帮大忙了,么么哒
6个月前
感谢,点赞,速度真快,么么哒
6个月前
感谢,点赞,帮大忙了,么么哒
7个月前
感谢,点赞,速度真快,帮大忙了,么么哒
7个月前
点赞,感谢,帮大忙了
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论